AMSTERDAM, Feb. 15, 2019 /PRNewswire/ --
VSY Biotechnology BV and Carl Zeiss Meditec AG jointly announced that both companies resolved their legal and patent disputes with respect to Tri-ED 611. The companies agreed not to disclose the terms of the settlement.
www.vsybiotechnology.com